3651 results for «211»
3651 results
TAVI in a bicuspid aortic valve
24 May 2019 – From EuroPCR 2019
A Medina 0,1,0 lesion
24 May 2019 – From EuroPCR 2019
Intermediate risk TAVI
23 May 2019 – From EuroPCR 2019
TAV in TAV for an 8-year old degenerating TAVI device - Session with LIVE case
19 Nov 2019 – From PCR London Valves 2019
Watch this session with a LIVE demonstration from St Thomas' Hospital - London, United Kingdom
TAVI device selection for severe aortic stenosis - Session with LIVE case
18 Nov 2019 – From PCR London Valves 2019
Watch this session with a LIVE demonstration from University Hospital of Zurich (Zurich, Switzerland) to learn more about TAVI device selection and « Best practice » implantation of the Portico Valve.
TAVI in bicuspid aortic valve disease - Session with LIVE case
19 Nov 2019 – From PCR London Valves 2019
Watch this session with LIVE demonstration from Clinique Pasteur - Toulouse, France
Transcatheter mitral valve-in-valve for a patient with a degenerating bioprosthesis - Session with LIVE case
18 Nov 2019 – From PCR London Valves 2019
Watch this session with a LIVE demonstration from St Thomas' Hospital - London, United Kingdom
TAVI for a patient with severe aortic stenosis and a mechanical mitral prosthesis - Session with LIVE case
18 Nov 2019 – From PCR London Valves 2019
View this session with a LIVE demonstration from St Thomas' Hospital - London, United Kingdom
PCR STATEMENT on the 2-year clinical outcomes from the Evolut low risk trial
18 May 2021
Transcatheter aortic valve implantation (TAVI) offers an effective, less invasive therapeutic alternative to surgical aortic valve replacement in patients with symptomatic, severe aortic stenosis. Although TAVI is demonstrated to be superior to medical therapy or surgery in patients who are at prohibitive or high risk for...
BioCardia reports positive interim results from phase III CardiAMP cell therapy heart failure trial, with compelling data in subgroup with elevated NTproBNP biomarker for heart failure.
04 Mar 2024
INFINITY-SWEDEHEART - Percutaneous coronary intervention with a bioadaptor compared to a contemporary drug eluting stent- one year primary outcomes
03 Sep 2024
Daniele Giacoppo provides his take on the main results of the INFINITY-SWEDEHEART trial presented by David Erlinge at the ESC Congress 2024 in London.
Author
